$62.51
0.590.95%
At close: -
$62.51
0.000.00%
After Hours: Apr 25, 4:00 PM EDT
Comments
Loading...
Haemonetics Earnings Estimates, EPS & Revenue | NYSE:HAE | Benzinga
Haemonetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$1.220
Quarterly Revenue Estimate
$329.38M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.37B
Analyze the earnings history of Haemonetics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HAE | Haemonetics | $0.90 | $1.22 | — | — | $343.29M | $329.38M | — | — | 05/08/2025 | Get Alert |
| HAE | Haemonetics | $1.04 | $1.17 | $1.19 | 1.71% | $336.25M | $352.88M | $348.54M | -1.23% | 02/06/2025 | Get Alert |
| HAE | Haemonetics | $0.99 | $1.07 | $1.12 | 4.67% | $318.18M | $342.65M | $345.51M | 0.83% | 11/07/2024 | Get Alert |
| HAE | Haemonetics | $1.05 | $1.00 | $1.02 | 2.00% | $311.33M | $335.38M | $336.17M | 0.24% | 08/08/2024 | Get Alert |
| HAE | Haemonetics | $0.77 | $0.89 | $0.90 | 1.12% | $304.42M | $329.11M | $343.29M | 4.31% | 05/09/2024 | Get Alert |
| HAE | Haemonetics | $0.85 | $0.94 | $1.04 | 10.64% | $305.30M | $320.29M | $336.25M | 4.98% | 02/08/2024 | Get Alert |
| HAE | Haemonetics | $0.83 | $0.89 | $0.99 | 11.24% | $297.49M | $313.12M | $318.18M | 1.62% | 11/02/2023 | Get Alert |
| HAE | Haemonetics | $0.58 | $0.76 | $1.05 | 38.16% | $261.46M | $297.92M | $311.33M | 4.50% | 08/08/2023 | Get Alert |
| HAE | Haemonetics | $0.65 | $0.70 | $0.77 | 10.00% | $265.00M | $289.64M | $304.42M | 5.10% | 05/11/2023 | Get Alert |
| HAE | Haemonetics | $0.84 | $0.80 | $0.85 | 6.25% | $259.77M | $300.47M | $305.30M | 1.61% | 02/07/2023 | Get Alert |
| HAE | Haemonetics | $0.60 | $0.67 | $0.83 | 23.88% | $239.90M | $269.22M | $297.49M | 10.50% | 11/07/2022 | Get Alert |
| HAE | Haemonetics | $0.50 | $0.51 | $0.58 | 13.73% | $228.53M | $249.00M | $261.46M | 5.00% | 08/10/2022 | Get Alert |
| HAE | Haemonetics | $0.46 | $0.60 | $0.65 | 8.33% | $225.03M | $257.82M | $265.00M | 2.79% | 05/10/2022 | Get Alert |
| HAE | Haemonetics | $0.81 | $0.73 | $0.84 | 15.07% | $240.37M | $266.74M | $259.77M | -2.61% | 02/08/2022 | Get Alert |
| HAE | Haemonetics | $0.62 | $0.61 | $0.60 | -1.64% | $209.49M | $241.40M | $239.90M | -0.62% | 11/09/2021 | Get Alert |
| HAE | Haemonetics | $0.46 | $0.46 | $0.50 | 8.70% | $195.58M | $219.35M | $228.53M | 4.18% | 08/11/2021 | Get Alert |
| HAE | Haemonetics | $0.69 | $0.67 | $0.46 | -31.34% | $238.49M | $222.98M | $225.03M | 0.92% | 05/13/2021 | Get Alert |
| HAE | Haemonetics | $0.94 | $0.65 | $0.81 | 24.62% | $258.97M | $224.29M | $240.37M | 7.17% | 02/02/2021 | Get Alert |
| HAE | Haemonetics | $0.87 | $0.51 | $0.62 | 21.57% | $252.57M | $207.65M | $209.49M | 0.88% | 11/04/2020 | Get Alert |
| HAE | Haemonetics | $0.81 | $0.41 | $0.46 | 12.20% | $238.45M | $198.27M | $195.58M | -1.36% | 08/04/2020 | Get Alert |
| HAE | Haemonetics | $0.61 | $0.73 | $0.69 | -5.48% | $249.29M | $247.15M | $238.49M | -3.50% | 05/05/2020 | Get Alert |
Haemonetics (HAE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-02-06 | $1.19 | $1.17 | 1.71 % |
| Q2 | 2024-11-07 | $1.12 | $1.07 | 4.67 % |
| Q1 | 2024-08-08 | $1.02 | $1.00 | 2.00 % |
| Q4 | 2024-05-09 | $0.90 | $0.89 | 1.12 % |
Haemonetics (HAE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-02-06 | $348.54M | $352.88M | -1.23 % |
| Q2 | 2024-11-07 | $345.51M | $342.65M | 0.83 % |
| Q1 | 2024-08-08 | $336.17M | $335.38M | 0.24 % |
| Q4 | 2024-05-09 | $343.29M | $329.11M | 4.31 % |
FAQ
When is Haemonetics (NYSE:HAE) reporting earnings?
Haemonetics (HAE) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 6, 2025 for Q3.
What were the latest earnings per share (EPS) for Haemonetics (NYSE:HAE)?
The Actual EPS was $1.19, which beat the estimate of $1.17.
What were Haemonetics’s (NYSE:HAE) revenues?
The Actual Revenue was $348.5M, which missed the estimate of $352.9M.
Browse earnings estimates, EPS, and revenue on all stocks.
